Maternal and Neonatal Outcomes After Membrane Sweeping

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-04-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aim to estimate maternal and neonatal outcomes after membrane sweeping in different group of patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety Study of Membrane Sweeping in Pregnancy

NCT00294242

Pregnancy Prelabor Rupture of Membranes

COMPLETED NA

Total Placenta Previa Associated With the Placenta Accreta Spectrum.

NCT06219564

Maternal; Procedure

COMPLETED NA

The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta

NCT02590484

Placenta Previa Placenta Previa Accreta

UNKNOWN NA

Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications

NCT03052686

Anomaly Uterus

COMPLETED

Amnioreduction in Polyhydramnios

NCT07067593

Polyhydramnios

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sweeping of the membranes is a simple technique usually performed during vaginal examination, in order to initiate labour by increasing local production of prostaglandins.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with a singleton pregnancy and confirmed cephalic presentation at or after 37 weeks of gestation who are candidate for vaginal delivery were eligible for the study

Exclusion Criteria

* Women with a multiple pregnancy, nonreassuring cardiotocogram, meconium stained amniotic fluid, major fetal anomalies, HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, or severe preeclampsia and signs of intrauterine infections were not eligible.
* women who are not candidates for vaginal delivery: placenta previa, breech presentation, planned repeat cesarean.

Minimum Eligible Age

17 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes